GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Pharmacy  (1)
Material
Language
Years
FID
  • Pharmacy  (1)
  • 1
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2022
    In:  Addiction Science & Clinical Practice Vol. 17, No. 1 ( 2022-12-14)
    In: Addiction Science & Clinical Practice, Springer Science and Business Media LLC, Vol. 17, No. 1 ( 2022-12-14)
    Abstract: Medication for opioid use disorder (MOUD) includes administering medications such as buprenorphine or methadone, often with mental health services. MOUD has been shown to significantly improve outcomes and success of recovery from opioid use disorder. In WV, only 18% of providers including physicians, physician assistants, and nurse practitioners are waivered, and 44% of non-waivered providers were not interested in free training even if compensated. This exploratory research seeks to understand intervention-related stigma in community-based primary care providers in rural West Virginia, determine whether financial incentives for training may be linked to levels of stigma, and what level of financial incentives would be required for non-adopters of MOUD services provision to obtain training. Method Survey questions were included in the West Virginia Practice-Based Research Network (WVPBRN) annual Collective Outreach & Research Engagement (CORE) Survey and delivered electronically to each practice site in WV. General demographic, staff attitudes and views on compensation for immersion training for delivering MOUD therapy in primary care offices were returned. Statistical analysis included logistic and multinomial logistic regression and an independent samples t-test. Results Data were collected from 102 participants. Perceived stigma did significantly predict having a waiver with every 1-unit increase in stigma being associated with a 65% decreased odds of possessing a waiver for buprenorphine/MOUD ( OR  = 0.35; 95% CI  0.16–0.78, p  = 0.01). Further, t-test analyses suggested there was a statistically significant mean difference in perceived stigma ( t (100) = 2.78, p  = 0.006) with those possessing a waiver ( M  = 1.56; SD  = 0.51) having a significantly lower perceived stigma than those without a waiver ( M  = 1.92; SD  = 0.57). There was no statistically significant association of stigma on whether someone with a waiver actually prescribed MOUD or not ( OR  = 0.28; 95% CI  0.04–2.27, p  = 0.234). Conclusion This survey of rural primary care providers demonstrates that stigmatizing beliefs related to MOUD impact the desired financial incentive to complete a one-day immersion, and that currently unwaivered providers endorse more stigmatizing beliefs about MOUD when compared to currently waivered providers. Furthermore, providers who endorse stigmatizing beliefs with respect to MOUD require higher levels of compensation to consider such training.
    Type of Medium: Online Resource
    ISSN: 1940-0640
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 2492632-2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...